首页 > 最新文献

INDONESIAN JOURNAL OF PHARMACY最新文献

英文 中文
Polyphenols as Tyrosine Kinase Inhibitors for the Treatment of Metastatic Cancers: Current and Future Perspective 多酚作为酪氨酸激酶抑制剂治疗转移性癌症:当前和未来的观点
IF 0.4 Q3 Health Professions Pub Date : 2022-06-20 DOI: 10.22146/ijp.3844
S. Hussain, Q. Alhadidi
Cancer is the world's biggest cause of death as a whole. The higher cancer mortality rate is related to metastasis, which is a major stumbling block in cancer treatment. Polyphenols are a diverse set of antioxidant-rich natural compounds that are often used in cancer treatments as chemopreventives and adjuvants. To find publications that highlight the topic of this review paper, a thorough literature search was conducted in several electronic databases such as PubMed Central, Google Scholar, Scopus, and Medline. Many signaling pathways are involved in the metastatic cascade, including the tyrosine kinase pathway. Tyrosine kinases are a group of enzymes involved in the control of cancer spread. Polyphenols' true role in cancer metastasis remains unappreciated, despite a large body of research proving their antimetastatic effects. As a result, the current work lays out cancer metastasis signaling pathways, stressing the importance of tyrosine kinases in the metastatic process. Polyphenols can suppress tyrosine kinase activity, which contributes to their antimetastatic characteristics. The importance of polyphenols in preventing cancer metastasis by interfering with the tyrosine kinase signaling cascade is highlighted in this work, which could lead to the development of future antimetastatic drugs.
癌症是世界上最大的死亡原因。癌症的高死亡率与转移有关,这是癌症治疗的主要障碍。多酚是一种富含抗氧化剂的天然化合物,常作为化学预防剂和佐剂用于癌症治疗。为了找到突出这篇综述论文主题的出版物,我们在PubMed Central、b谷歌Scholar、Scopus和Medline等几个电子数据库中进行了全面的文献检索。许多信号通路参与转移级联,包括酪氨酸激酶途径。酪氨酸激酶是一组参与控制癌症扩散的酶。尽管大量研究证明了多酚的抗转移作用,但它在癌症转移中的真正作用仍未得到充分认识。因此,目前的研究阐明了癌症转移的信号通路,强调了酪氨酸激酶在转移过程中的重要性。多酚可以抑制酪氨酸激酶活性,这有助于它们的抗转移特性。本研究强调了多酚通过干扰酪氨酸激酶信号级联在预防癌症转移中的重要性,这可能会导致未来抗转移药物的开发。
{"title":"Polyphenols as Tyrosine Kinase Inhibitors for the Treatment of Metastatic Cancers: Current and Future Perspective","authors":"S. Hussain, Q. Alhadidi","doi":"10.22146/ijp.3844","DOIUrl":"https://doi.org/10.22146/ijp.3844","url":null,"abstract":"Cancer is the world's biggest cause of death as a whole. The higher cancer mortality rate is related to metastasis, which is a major stumbling block in cancer treatment. Polyphenols are a diverse set of antioxidant-rich natural compounds that are often used in cancer treatments as chemopreventives and adjuvants. To find publications that highlight the topic of this review paper, a thorough literature search was conducted in several electronic databases such as PubMed Central, Google Scholar, Scopus, and Medline. Many signaling pathways are involved in the metastatic cascade, including the tyrosine kinase pathway. Tyrosine kinases are a group of enzymes involved in the control of cancer spread. Polyphenols' true role in cancer metastasis remains unappreciated, despite a large body of research proving their antimetastatic effects. As a result, the current work lays out cancer metastasis signaling pathways, stressing the importance of tyrosine kinases in the metastatic process. Polyphenols can suppress tyrosine kinase activity, which contributes to their antimetastatic characteristics. The importance of polyphenols in preventing cancer metastasis by interfering with the tyrosine kinase signaling cascade is highlighted in this work, which could lead to the development of future antimetastatic drugs.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81289083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Y-Site Incompatibility of Intravenous Medication: A Systematic Review 静脉用药y位点不相容的处理:系统综述
IF 0.4 Q3 Health Professions Pub Date : 2022-06-15 DOI: 10.22146/ijp.2262
S. Hanifah, P. Ball, R. Kennedy
Patients in intensive care units have a critical problem with Intravenous (IC) drug administration. The effort to decrease incompatibility or manage the incompatibility risks is paramount significant to reduce morbidity and mortality. This review collates all published studies about kinds of approaches to prevent or solve y-site incompatibility, evaluate the effectiveness of those approaches, and provide the recommendation. A scoping review was conducted in PUBMED in a time frame 1 Januari 2010- 28 February 2021. All type studies of randomised controlled trials, observational studies, before and after studies, also review articled were considered to include. We identified 944 studies; of these, 78 met the inclusion criteria, but 44 were excluded. A total 34 articles were included in the analyses.  Six articles reported protocol, two-dimensional chart, database, or pH colour code to provide information of incompatibilities. Two-dimensional chart and pH code were comparable with a gold standard. Specific protocol markedly reduced the incompatibility event. Normal saline (NS) flushing effectively prolonged patency and reduced the incompatibility rate. NS was preferred over heparin associated with thrombocytopenia. In-line filtration has been proved to reduce particulate matter, as well as the precipitation, resulted from incompatibility. The filter also reduced inflammation, infection, and complication appreciably. Four studies used more than three lumen catheters which successfully decrease the number of precipitation and incompatibility events. Therefore, separating incompatible drugs using multi-lumens according to the chart should be preferred. However, when co-administration is inevitable, flushing or filter is needed.
重症监护病房的患者有静脉注射(IC)药物管理的关键问题。努力减少不相容或管理不相容风险对降低发病率和死亡率至关重要。本文对已发表的关于预防或解决y位不相容的各种方法的研究进行了整理,评价了这些方法的有效性,并提出了建议。PUBMED在2010年1月1日至2021年2月28日期间进行了范围审查。所有类型的随机对照试验、观察性研究、前后研究以及综述文章均被纳入。我们确定了944项研究;其中78例符合纳入标准,44例被排除在外。共有34篇文章被纳入分析。六篇文章报道了方案、二维图表、数据库或pH值色码,以提供不兼容信息。二维图和pH值与金标准比较。特定协议显著减少了不兼容事件。生理盐水冲洗可有效延长通畅,降低不相容率。NS优于与血小板减少相关的肝素。在线过滤已被证明可以减少由于不相容而产生的颗粒物和降水。过滤器也明显减少炎症、感染和并发症。四项研究使用了三个以上的管腔导管,成功地减少了沉淀和不相容事件的数量。因此,应优先根据图表使用多腔分离不相容药物。然而,当必须同时给药时,需要冲洗或过滤。
{"title":"Management of Y-Site Incompatibility of Intravenous Medication: A Systematic Review","authors":"S. Hanifah, P. Ball, R. Kennedy","doi":"10.22146/ijp.2262","DOIUrl":"https://doi.org/10.22146/ijp.2262","url":null,"abstract":"Patients in intensive care units have a critical problem with Intravenous (IC) drug administration. The effort to decrease incompatibility or manage the incompatibility risks is paramount significant to reduce morbidity and mortality. This review collates all published studies about kinds of approaches to prevent or solve y-site incompatibility, evaluate the effectiveness of those approaches, and provide the recommendation. A scoping review was conducted in PUBMED in a time frame 1 Januari 2010- 28 February 2021. All type studies of randomised controlled trials, observational studies, before and after studies, also review articled were considered to include. We identified 944 studies; of these, 78 met the inclusion criteria, but 44 were excluded. A total 34 articles were included in the analyses.  Six articles reported protocol, two-dimensional chart, database, or pH colour code to provide information of incompatibilities. Two-dimensional chart and pH code were comparable with a gold standard. Specific protocol markedly reduced the incompatibility event. Normal saline (NS) flushing effectively prolonged patency and reduced the incompatibility rate. NS was preferred over heparin associated with thrombocytopenia. In-line filtration has been proved to reduce particulate matter, as well as the precipitation, resulted from incompatibility. The filter also reduced inflammation, infection, and complication appreciably. Four studies used more than three lumen catheters which successfully decrease the number of precipitation and incompatibility events. Therefore, separating incompatible drugs using multi-lumens according to the chart should be preferred. However, when co-administration is inevitable, flushing or filter is needed.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77986536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pharmacists’ Roles and Practices in Pharmaceutical Services During Covid-19 Pandemic: a Qualitative Study 新冠肺炎大流行期间药师在药学服务中的角色与实践:一项定性研究
IF 0.4 Q3 Health Professions Pub Date : 2022-06-15 DOI: 10.22146/ijp.2435
Anna Wahyuni Widayanti, Shahiroh Haulaini, S. A. Kristina
The World Health Organization (WHO) declared COVID-19 a global pandemic on March 11, 2020. Pharmacists as health workers also have an important role in this pandemic. This study wants to look deeper into how pharmacists perceive their role and pharmaceutical services during this pandemic. A qualitative study with Focus Group Discussions (FGDs) was utilized. Fifteen pharmacists from Kepulauan Riau province were involved. They were purposively selected to include pharmacists from the community pharmacies, hospitals, and community health centers. The FGDs were conducted with Zoom meetings and were recorded. The data were then transcribed and analyzed with inductive content analysis.  This study found five themes with 18 sub-themes. The five themes are the roles and efforts of pharmacists in managing medicines, medical devices, and disposable medical materials (personal protective equipment); the roles of pharmacists in providing pharmaceutical care; community behaviors during the pandemic; development of pharmacists’  roles and capacity during the pandemic; and external factors influencing the roles and practice of pharmacists during the pandemic. During the pandemic, pharmacists continued to work according to their previous roles and adjusted their roles and practice in pharmaceutical services to follow changes in community behaviors.  This condition also encouraged pharmacists to develop their roles and capacities. The healthcare management team, the government, and the professional organizations influenced their roles, both positively and negatively. The results of this study provide a deeper understanding of pharmacist roles and practices during the pandemic. This understanding will be useful for the pharmacist in developing their potential and capability to be involved as healthcare professionals, specifically during the pandemic situation and generally in disaster management.
2020年3月11日,世界卫生组织宣布新冠肺炎为全球大流行。药剂师作为卫生工作者在这次大流行中也发挥着重要作用。这项研究希望更深入地了解药剂师在这次大流行期间如何看待他们的角色和药物服务。采用焦点小组讨论(fgd)进行定性研究。来自廖内省的15名药剂师参与了调查。他们有目的地选择了来自社区药房、医院和社区卫生中心的药剂师。fgd与Zoom会议一起进行,并被记录下来。然后对数据进行转录和归纳内容分析。这项研究发现了5个主题和18个子主题。五个主题是药剂师在管理药品、医疗器械和一次性医疗材料(个人防护装备)方面的作用和努力;药师在药学服务中的作用疫情期间的社区行为;大流行期间药师角色和能力的发展大流行期间影响药师角色和执业的外部因素。大流行期间,药师继续按原有角色开展工作,并根据社区行为变化调整其在药学服务中的角色和实践。这种情况也鼓励药剂师发展他们的角色和能力。医疗管理团队、政府和专业组织对他们的角色产生了积极和消极的影响。这项研究的结果提供了一个更深入的了解药剂师的作用和做法在大流行。这种理解将有助于药剂师开发他们作为医疗保健专业人员的潜力和能力,特别是在大流行情况下和一般的灾害管理中。
{"title":"Pharmacists’ Roles and Practices in Pharmaceutical Services During Covid-19 Pandemic: a Qualitative Study","authors":"Anna Wahyuni Widayanti, Shahiroh Haulaini, S. A. Kristina","doi":"10.22146/ijp.2435","DOIUrl":"https://doi.org/10.22146/ijp.2435","url":null,"abstract":"The World Health Organization (WHO) declared COVID-19 a global pandemic on March 11, 2020. Pharmacists as health workers also have an important role in this pandemic. This study wants to look deeper into how pharmacists perceive their role and pharmaceutical services during this pandemic. A qualitative study with Focus Group Discussions (FGDs) was utilized. Fifteen pharmacists from Kepulauan Riau province were involved. They were purposively selected to include pharmacists from the community pharmacies, hospitals, and community health centers. The FGDs were conducted with Zoom meetings and were recorded. The data were then transcribed and analyzed with inductive content analysis.  This study found five themes with 18 sub-themes. The five themes are the roles and efforts of pharmacists in managing medicines, medical devices, and disposable medical materials (personal protective equipment); the roles of pharmacists in providing pharmaceutical care; community behaviors during the pandemic; development of pharmacists’  roles and capacity during the pandemic; and external factors influencing the roles and practice of pharmacists during the pandemic. During the pandemic, pharmacists continued to work according to their previous roles and adjusted their roles and practice in pharmaceutical services to follow changes in community behaviors.  This condition also encouraged pharmacists to develop their roles and capacities. The healthcare management team, the government, and the professional organizations influenced their roles, both positively and negatively. The results of this study provide a deeper understanding of pharmacist roles and practices during the pandemic. This understanding will be useful for the pharmacist in developing their potential and capability to be involved as healthcare professionals, specifically during the pandemic situation and generally in disaster management.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80566950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Application of Molecular spectroscopy and chemometrics for authentication and quality control of tea (Camellia sinensis L.): a review 分子光谱和化学计量学在茶树鉴别和质量控制中的应用综述
IF 0.4 Q3 Health Professions Pub Date : 2022-06-15 DOI: 10.22146/ijp.4817
Mitsalina Fildzah Arifah, Agustina A. M. B. Hastuti, A. Rohman
Tea, derived from Camellia sinensis L., is considered as the most popular beverages in the world. The quality of teas may vary depending on harvesting location and geographical origins, thus the traceability of teas according to their origins is very essential to assure tea’s quality. Due to economic reasons, high quality tea products may be added with foreign materials or adulterated with low quality ones, as a consequence, some analytical methods have been proposed and developed to quality control of tea. During the recent years, the application of molecular spectroscopic techniques (UV-Vis, Fluorescence, Near Infrared, Mid Infrared, Raman) in combination with multivariate data analysis has emerged as rapid and reliable analytical tool in the quality control of food, including food authentication. The objective of this review is to update the application of molecular spectroscopy (UV-Vis, fluorescence, infrared and Raman) for the quality control and authentication of tea products either geographical origins issue or detection of potential adulterants. The variables obtained during molecular spectral measurement involve hundreds or thousands of data, which make data analysis rather complex. Fortunately, the specific chemometrics tools can solve the problems arising from big data coming from analyte signals, spectral interferences and overlapping peaks. This review paper provides an overview of the recently developed approaches and latest research carried out in molecular spectroscopic techniques in combination with chemometrics for the quality control and for authentication of teas
茶,源自茶树,被认为是世界上最受欢迎的饮料。茶叶的质量可能会因采收地点和地理来源而有所不同,因此根据其来源对茶叶的可追溯性对于保证茶叶的质量至关重要。由于经济原因,高质量的茶叶产品可能会添加外来物质或掺入劣质物质,因此人们提出并发展了一些茶叶质量控制的分析方法。近年来,分子光谱技术(紫外可见、荧光、近红外、中红外、拉曼)与多变量数据分析相结合的应用,成为食品质量控制,包括食品认证的快速、可靠的分析工具。本文综述了分子光谱(UV-Vis、荧光、红外和拉曼光谱)在茶叶产品质量控制和认证中的最新应用,包括地理来源问题和潜在掺假检测。在分子光谱测量中获得的变量涉及成百上千个数据,这使得数据分析相当复杂。幸运的是,特定的化学计量学工具可以解决来自分析物信号、光谱干扰和重叠峰的大数据带来的问题。本文综述了分子光谱技术与化学计量学相结合用于茶叶质量控制和鉴别的最新进展和研究进展
{"title":"Application of Molecular spectroscopy and chemometrics for authentication and quality control of tea (Camellia sinensis L.): a review","authors":"Mitsalina Fildzah Arifah, Agustina A. M. B. Hastuti, A. Rohman","doi":"10.22146/ijp.4817","DOIUrl":"https://doi.org/10.22146/ijp.4817","url":null,"abstract":"Tea, derived from Camellia sinensis L., is considered as the most popular beverages in the world. The quality of teas may vary depending on harvesting location and geographical origins, thus the traceability of teas according to their origins is very essential to assure tea’s quality. Due to economic reasons, high quality tea products may be added with foreign materials or adulterated with low quality ones, as a consequence, some analytical methods have been proposed and developed to quality control of tea. During the recent years, the application of molecular spectroscopic techniques (UV-Vis, Fluorescence, Near Infrared, Mid Infrared, Raman) in combination with multivariate data analysis has emerged as rapid and reliable analytical tool in the quality control of food, including food authentication. The objective of this review is to update the application of molecular spectroscopy (UV-Vis, fluorescence, infrared and Raman) for the quality control and authentication of tea products either geographical origins issue or detection of potential adulterants. The variables obtained during molecular spectral measurement involve hundreds or thousands of data, which make data analysis rather complex. Fortunately, the specific chemometrics tools can solve the problems arising from big data coming from analyte signals, spectral interferences and overlapping peaks. This review paper provides an overview of the recently developed approaches and latest research carried out in molecular spectroscopic techniques in combination with chemometrics for the quality control and for authentication of teas","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86564580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Media and Blanching Time on the Antioxidative Properties of Curcuma aeruginosa Roxb. 培养基和焯水时间对铜绿姜黄抗氧化性能的影响。
IF 0.4 Q3 Health Professions Pub Date : 2022-06-06 DOI: 10.22146/ijp.3634
D. Pujimulyani, Sulkhan Windrayahya, I. Irnawati
Black saffron (Curcuma aeruginosa Roxb.) belongs to the family of Zingiberaceae is one of rhizomes widely used as raw material in Indonesian Traditional Medicines. Black saffron (BS) contains some bioactive compounds responsible for certain biological activities including antioxidant. Blanching has been reported to increase the antioxidant activity of BS. This study aims to formulate BS containing high antioxidant activity. This research was performed by varying blanching medium (citric acid and aquadest) and blanching time (0; 2.5; 5; 7.5 and 10 min). The fabrication stage of BS powder included peeling, cleaning, blanching, slicing drying, grinding, and sieving. After that, the treated BS was analyzed for the antioxidant activity, total phenolic, total flavonoid, tannin, crude fiber, and water contents. BS powder subjected to blanching process showed better antioxidant activity than that without blanching process. Blanching using citric acid media 0.05% for 5 min showed the best antioxidant activities, as indicated by high contents of total phenolic, total flavonoid, and tannins. Powdered BS is potential to be used as materials to be applied as fortifying agents in food products.
黑藏红花(Curcuma aeruginosa Roxb.)属于姜科(Zingiberaceae),是印尼传统医药中广泛用作原料的根茎植物之一。黑藏红花(BS)含有一些生物活性化合物,负责某些生物活性,包括抗氧化。据报道,焯水可以提高BS的抗氧化活性。本研究旨在制备具有高抗氧化活性的BS。本研究采用不同的漂烫介质(柠檬酸和aquadest)和漂烫时间(0;2.5;5;7.5和10分钟)。BS粉体的制备过程包括剥离、清洗、漂烫、切片、干燥、研磨、过筛。然后,对处理后的BS进行抗氧化活性、总酚、总黄酮、单宁、粗纤维和水分含量的分析。经漂烫处理的BS粉的抗氧化活性优于未经漂烫处理的。用0.05%柠檬酸溶液焯水5 min,总酚、总黄酮和单宁含量较高,具有较好的抗氧化活性。粉末状BS具有作为食品强化剂的潜力。
{"title":"The Effects of Media and Blanching Time on the Antioxidative Properties of Curcuma aeruginosa Roxb.","authors":"D. Pujimulyani, Sulkhan Windrayahya, I. Irnawati","doi":"10.22146/ijp.3634","DOIUrl":"https://doi.org/10.22146/ijp.3634","url":null,"abstract":"Black saffron (Curcuma aeruginosa Roxb.) belongs to the family of Zingiberaceae is one of rhizomes widely used as raw material in Indonesian Traditional Medicines. Black saffron (BS) contains some bioactive compounds responsible for certain biological activities including antioxidant. Blanching has been reported to increase the antioxidant activity of BS. This study aims to formulate BS containing high antioxidant activity. This research was performed by varying blanching medium (citric acid and aquadest) and blanching time (0; 2.5; 5; 7.5 and 10 min). The fabrication stage of BS powder included peeling, cleaning, blanching, slicing drying, grinding, and sieving. After that, the treated BS was analyzed for the antioxidant activity, total phenolic, total flavonoid, tannin, crude fiber, and water contents. BS powder subjected to blanching process showed better antioxidant activity than that without blanching process. Blanching using citric acid media 0.05% for 5 min showed the best antioxidant activities, as indicated by high contents of total phenolic, total flavonoid, and tannins. Powdered BS is potential to be used as materials to be applied as fortifying agents in food products.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82794727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cyclooxygenase (COX) and 15-Lipoxygenase (15-LOX) Inhibitory Activity and HPTLC Profile of Asplenium Nidus, Diplazium Esculentum, and Drynaria Quercifolia in Bukidnon, Philippines 菲律宾Bukidnon地区仙桃、猕猴桃和槲皮草环氧合酶(COX)和15-脂氧合酶(15-LOX)抑制活性及HPTLC谱
IF 0.4 Q3 Health Professions Pub Date : 2022-06-02 DOI: 10.22146/ijp.3975
A. Ang, Roxan D. Sabesaje, G. Barbosa, R. Y. D. Cruz, Rainear A. Mendez, Melania M. Enot
Diplazium esculentum, Drynaria quercifolia, and Asplenium nidus are among the fern species found in Bukidnon, Philippines which are used as traditional herbal medicines.  The HPTLC profile and the anti-inflammatory properties against cyclooxygenase (COX) and 15-lipoxygenase (15-LOX) of the frond ethanolic extracts of D. esculentum, D. quercifolia, and A. nidus were determined.  The High-Performance Thin Layer Chromatography (HPTLC) profile was obtained using ethyl acetate: formic acid: water (16:2:2) as mobile phase and Natural Products (NP) as derivatizing reagent.  The HPTLC profile of the D. esculentum, D. quercifolia, and A. nidus extracts showed 10 (Rf = 0.02-0.97), 13 (Rf = 0.03-0.90), and 14 (Rf = 0.02-0.99) bands, respectively. The profiles for each fern species may be used as marker for quality evaluation and standardization of herbal formulations containing these plants.  For the anti-inflammatory properties, D. esculentum and D. quercifolia extracts which inhibited more than 50% of the COX enzymes showed significantly higher activity than A. nidus and were considered active against COX-2 and COX-1. D. esculentum, however, gave a selectivity ratio (COX-2/COX-1) of 1.03 making its inhibitory activity selective against COX-2.  The percent 15-LOX inhibitory activity of D. quercifolia (58.62%) is significantly higher than that of A. nidus (38.70%) but statistically comparable to D. esculentum (51.19%).  Among the extracts, D. quercifolia and D. esculentum which inhibited more than 50% of the 15-LOX were considered active. D. esculentum and D. quercifolia can therefore be potential sources of anti-inflammatory lead compounds for future drug development.   
在菲律宾Bukidnon发现的蕨类植物中,有双蕨、槲皮树和野蕨,它们被用作传统草药。采用HPTLC谱法测定了三种植物叶面乙醇提取物的环氧合酶(COX)和15-脂氧合酶(15-LOX)抗炎活性。以乙酸乙酯:甲酸:水(16:2:2)为流动相,天然产物(NP)为衍生试剂,建立了高效薄层色谱(HPTLC)图谱。槲皮提取物、槲皮提取物和荆芥提取物的HPTLC谱图分别显示出10个(Rf = 0.02 ~ 0.97)、13个(Rf = 0.03 ~ 0.90)和14个(Rf = 0.02 ~ 0.99)波段。各蕨类植物的谱图可作为含有这些植物的中药制剂质量评价和标准化的标志。对COX-2和COX-1有抑制作用,对50%以上的COX酶有抑制作用,槲皮提取物和金针叶提取物的抗炎活性显著高于金针叶提取物。而对COX-2的选择性比(COX-2/COX-1)为1.03,对COX-2具有选择性抑制活性。槲皮对15-LOX的抑制率为58.62%,显著高于野金针桃(38.70%),与黄金针桃(51.19%)无统计学差异。其中,槲皮和木皮提取物对15-LOX的抑制作用大于50%,具有一定的活性。因此,栓皮栎和槲皮可能是未来药物开发中抗炎先导化合物的潜在来源。
{"title":"Cyclooxygenase (COX) and 15-Lipoxygenase (15-LOX) Inhibitory Activity and HPTLC Profile of Asplenium Nidus, Diplazium Esculentum, and Drynaria Quercifolia in Bukidnon, Philippines","authors":"A. Ang, Roxan D. Sabesaje, G. Barbosa, R. Y. D. Cruz, Rainear A. Mendez, Melania M. Enot","doi":"10.22146/ijp.3975","DOIUrl":"https://doi.org/10.22146/ijp.3975","url":null,"abstract":"Diplazium esculentum, Drynaria quercifolia, and Asplenium nidus are among the fern species found in Bukidnon, Philippines which are used as traditional herbal medicines.  The HPTLC profile and the anti-inflammatory properties against cyclooxygenase (COX) and 15-lipoxygenase (15-LOX) of the frond ethanolic extracts of D. esculentum, D. quercifolia, and A. nidus were determined.  The High-Performance Thin Layer Chromatography (HPTLC) profile was obtained using ethyl acetate: formic acid: water (16:2:2) as mobile phase and Natural Products (NP) as derivatizing reagent.  The HPTLC profile of the D. esculentum, D. quercifolia, and A. nidus extracts showed 10 (Rf = 0.02-0.97), 13 (Rf = 0.03-0.90), and 14 (Rf = 0.02-0.99) bands, respectively. The profiles for each fern species may be used as marker for quality evaluation and standardization of herbal formulations containing these plants.  For the anti-inflammatory properties, D. esculentum and D. quercifolia extracts which inhibited more than 50% of the COX enzymes showed significantly higher activity than A. nidus and were considered active against COX-2 and COX-1. D. esculentum, however, gave a selectivity ratio (COX-2/COX-1) of 1.03 making its inhibitory activity selective against COX-2.  The percent 15-LOX inhibitory activity of D. quercifolia (58.62%) is significantly higher than that of A. nidus (38.70%) but statistically comparable to D. esculentum (51.19%).  Among the extracts, D. quercifolia and D. esculentum which inhibited more than 50% of the 15-LOX were considered active. D. esculentum and D. quercifolia can therefore be potential sources of anti-inflammatory lead compounds for future drug development.   ","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75771648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Somatostatin Analog-Based Radiopharmaceuticals for Molecular Imaging and Therapy of Neuroendocrine Tumors 基于生长抑素类似物的放射药物用于神经内分泌肿瘤的分子成像和治疗
IF 0.4 Q3 Health Professions Pub Date : 2022-05-11 DOI: 10.22146/ijp.2514
Rien Ritawidya, C. Palangka, T. S. Humani, V. Y. Susilo, Ilma Darojatin, Anung Pujiyanto
Somatostatin receptors (SSTRs) are overexpressed in a wide variety of cancers such as neuroendocrine tumors (NETs), but the expression in normal cells is relatively low. Therefore, SSTRs serve a potential target for molecular imaging and therapeutic applications of NETs. This review presents the development of somatostatin analog-labeled with gamma-emitting radionuclides such as 111In, 99mTc, and 123I for the visualization of NETs via single-photon emission tomography (SPECT). Additionally, the development of somatostatin analog-radiolabeled with positron emitting radionuclide such as 68Ga for the molecular imaging of NETs with positron emission tomography (PET) is also presented herein. Moreover, this review describes 177Lu-, 90Y-, and 111In-labeled somatostatin analogs as peptide receptor radionuclide therapy (PRRT) agents for the therapeutic application of NETs. These radiolabeled-somatostatin analogs showed promising results with good images quality and high tumor uptake. These results highlight the potential application of radiopharmaceuticals-based somatostatin analogs for the molecular imaging and targeted treatment of NETs.
生长抑素受体(SSTRs)在神经内分泌肿瘤(NETs)等多种癌症中过表达,但在正常细胞中的表达相对较低。因此,sstr是NETs分子成像和治疗应用的潜在靶点。本文综述了用γ -发射核素(如111In, 99mTc和123I)标记的生长抑素类似物的发展,用于通过单光子发射断层扫描(SPECT)显示NETs。此外,本文还介绍了用正电子发射核素(如68Ga)对生长抑素类似物进行放射性标记的研究进展,用于NETs的正电子发射断层扫描(PET)分子成像。此外,本文综述了177Lu-, 90Y-和111in标记的生长抑素类似物作为肽受体放射性核素治疗(PRRT)药物用于NETs的治疗应用。这些放射性标记的生长抑素类似物显示出良好的图像质量和高肿瘤摄取的前景。这些结果突出了基于放射性药物的生长抑素类似物在NETs分子成像和靶向治疗中的潜在应用。
{"title":"Somatostatin Analog-Based Radiopharmaceuticals for Molecular Imaging and Therapy of Neuroendocrine Tumors","authors":"Rien Ritawidya, C. Palangka, T. S. Humani, V. Y. Susilo, Ilma Darojatin, Anung Pujiyanto","doi":"10.22146/ijp.2514","DOIUrl":"https://doi.org/10.22146/ijp.2514","url":null,"abstract":"Somatostatin receptors (SSTRs) are overexpressed in a wide variety of cancers such as neuroendocrine tumors (NETs), but the expression in normal cells is relatively low. Therefore, SSTRs serve a potential target for molecular imaging and therapeutic applications of NETs. This review presents the development of somatostatin analog-labeled with gamma-emitting radionuclides such as 111In, 99mTc, and 123I for the visualization of NETs via single-photon emission tomography (SPECT). Additionally, the development of somatostatin analog-radiolabeled with positron emitting radionuclide such as 68Ga for the molecular imaging of NETs with positron emission tomography (PET) is also presented herein. Moreover, this review describes 177Lu-, 90Y-, and 111In-labeled somatostatin analogs as peptide receptor radionuclide therapy (PRRT) agents for the therapeutic application of NETs. These radiolabeled-somatostatin analogs showed promising results with good images quality and high tumor uptake. These results highlight the potential application of radiopharmaceuticals-based somatostatin analogs for the molecular imaging and targeted treatment of NETs.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83524713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cocrystals of Cefixime with Nicotinamide: Improved Solubility, Dissolution, and Permeability 头孢克肟与烟酰胺共晶:改善溶解度、溶出度和渗透性
IF 0.4 Q3 Health Professions Pub Date : 2022-04-28 DOI: 10.22146/ijp.2530
Abulkhair Abdullah, M. Mutmainnah, E. R. Wikantyasning
Cefixime is a third-generation cephalosporin antibiotic with poor solubility and permeability. The aim was to compared between Dry Grinding (DG) and Liquid-Assisted Grinding (LAG) methods to formed cocrystal of cefixime with nicotinamide. Cocrystal was prepared in 1:1 molar ratio and was characterizated by differential scanning calorimetry (DSC), fourier transform infra-red (FTIR), scanning electron microscopy (SEM), x-ray diffraction (XRD) methods. Cocrystal properties such as solubility, dissolution rate, and permeation rate were evaluated. The solubility test results obtained: 0.420 ± 0.016 (cefixime); 0.675 ± 0.016 (cocrystal 1:1 LAG); and 0.632 ± 0.016 (cocrystal 1:1 DG). The dissolution test results obtained: 186.55 ± 4.18 (cefixime); 232.83 ± 4.07 (cocrystal 1:1 LAG); and 228.82 ± 10.07 (cocrystal 1:1 DG). The permeability test results obtained: 153.58 ± 31.94 (cefixime); 306.22 ± 77.81 (cocrystal 1:1 LAG); and 211.44 ± 22.90 (cocrystal 1:1 DG). Cefixime can be formed into cocrystal with nicotinamide by DG and LAG methods according to the results of characterization using DSC, FTIR, SEM, and XRD accompanied by the increasing solubility, dissolution, and permeability. Cocrystal 1:1 LAG showed better result compared to cocrystal 1:1 DG.
头孢克肟是第三代头孢菌素类抗生素,其溶解度和渗透性较差。目的是比较干磨法(DG)和液助磨法(LAG)制备头孢克肟与烟酰胺共晶的方法。采用差示扫描量热法(DSC)、傅里叶变换红外(FTIR)、扫描电镜(SEM)、x射线衍射(XRD)等方法对共晶进行了表征。评价了共晶的溶解度、溶解速率和渗透速率等特性。溶度试验结果为:0.420±0.016(头孢克肟);0.675±0.016(共晶1:1 LAG);和0.632±0.016(共晶1:1 DG)。溶出度试验结果得到:186.55±4.18(头孢克肟);232.83±4.07(共晶1:1 LAG);228.82±10.07(共晶1:1 DG)。渗透性试验结果为:153.58±31.94(头孢克肟);306.22±77.81(共晶1:1 LAG);211.44±22.90(共晶1:1 DG)。DSC、FTIR、SEM、XRD等表征结果表明,用DG和LAG方法可与烟酰胺形成共晶,且其溶解度、溶出度和渗透性均增加。与共晶1:1 DG相比,共晶1:1 LAG效果更好。
{"title":"Cocrystals of Cefixime with Nicotinamide: Improved Solubility, Dissolution, and Permeability","authors":"Abulkhair Abdullah, M. Mutmainnah, E. R. Wikantyasning","doi":"10.22146/ijp.2530","DOIUrl":"https://doi.org/10.22146/ijp.2530","url":null,"abstract":"Cefixime is a third-generation cephalosporin antibiotic with poor solubility and permeability. The aim was to compared between Dry Grinding (DG) and Liquid-Assisted Grinding (LAG) methods to formed cocrystal of cefixime with nicotinamide. Cocrystal was prepared in 1:1 molar ratio and was characterizated by differential scanning calorimetry (DSC), fourier transform infra-red (FTIR), scanning electron microscopy (SEM), x-ray diffraction (XRD) methods. Cocrystal properties such as solubility, dissolution rate, and permeation rate were evaluated. The solubility test results obtained: 0.420 ± 0.016 (cefixime); 0.675 ± 0.016 (cocrystal 1:1 LAG); and 0.632 ± 0.016 (cocrystal 1:1 DG). The dissolution test results obtained: 186.55 ± 4.18 (cefixime); 232.83 ± 4.07 (cocrystal 1:1 LAG); and 228.82 ± 10.07 (cocrystal 1:1 DG). The permeability test results obtained: 153.58 ± 31.94 (cefixime); 306.22 ± 77.81 (cocrystal 1:1 LAG); and 211.44 ± 22.90 (cocrystal 1:1 DG). Cefixime can be formed into cocrystal with nicotinamide by DG and LAG methods according to the results of characterization using DSC, FTIR, SEM, and XRD accompanied by the increasing solubility, dissolution, and permeability. Cocrystal 1:1 LAG showed better result compared to cocrystal 1:1 DG.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86465605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Delivery of Potential Drugs to The Colon: Challenges and Strategies 给结肠输送潜在药物:挑战和策略
IF 0.4 Q3 Health Professions Pub Date : 2022-04-22 DOI: 10.22146/ijp.2734
R. Iswandana, K. Putri, Sekar Arum Larasati, Maxius Gunawan, Fathia Amalia Putri
Colon-targeted drug delivery systems have been exploited to treat local diseases in the colon, systemic delivery of protein and peptide, and chronotherapeutic drugs. The upper gastrointestinal tract restricts the effective delivery of these drugs. Therefore, several strategies are needed for targeted drugs directly to the colon, such as pH-sensitive polymers, enzyme-sensitive polymers, bacterially degradable polysaccharides, time-dependent polymers, and particulate systems. However, variable physiological conditions of the gastrointestinal tract in individuals cause combinations of these strategies are needed to ensure colonic delivery of the drug. This review presents and discusses several potential drugs and their approaches used to design and develop colon-targeted drug delivery systems for medications with particular characteristics.
结肠靶向药物递送系统已被用于治疗结肠局部疾病、蛋白质和肽的全身递送以及时间治疗药物。上胃肠道限制了这些药物的有效递送。因此,需要几种策略来直接靶向结肠药物,如ph敏感聚合物、酶敏感聚合物、细菌可降解多糖、时间依赖性聚合物和颗粒系统。然而,个体胃肠道的可变生理条件导致这些策略的组合需要确保药物的结肠递送。本文介绍并讨论了几种潜在的药物及其用于设计和开发具有特定特征的结肠靶向给药系统的方法。
{"title":"Delivery of Potential Drugs to The Colon: Challenges and Strategies","authors":"R. Iswandana, K. Putri, Sekar Arum Larasati, Maxius Gunawan, Fathia Amalia Putri","doi":"10.22146/ijp.2734","DOIUrl":"https://doi.org/10.22146/ijp.2734","url":null,"abstract":"Colon-targeted drug delivery systems have been exploited to treat local diseases in the colon, systemic delivery of protein and peptide, and chronotherapeutic drugs. The upper gastrointestinal tract restricts the effective delivery of these drugs. Therefore, several strategies are needed for targeted drugs directly to the colon, such as pH-sensitive polymers, enzyme-sensitive polymers, bacterially degradable polysaccharides, time-dependent polymers, and particulate systems. However, variable physiological conditions of the gastrointestinal tract in individuals cause combinations of these strategies are needed to ensure colonic delivery of the drug. This review presents and discusses several potential drugs and their approaches used to design and develop colon-targeted drug delivery systems for medications with particular characteristics.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86413526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison of the Mortality and Bleeding Risk of Anticoagulant Doses in COVID-19 Patients: A Systematic Review and Meta-analysis COVID-19患者抗凝剂剂量死亡率和出血风险的比较:系统回顾和荟萃分析
IF 0.4 Q3 Health Professions Pub Date : 2022-04-22 DOI: 10.22146/ijp.2697
A. F. Purnomo, M. Syaban, I. Faratisha, Firstya Diyah Ekasiwi, M. Juwono, Nur Hudayana, Edwin Kinesya, Yusuf Mannagalli, E. Pasaribu
Anticoagulant therapy becomes critical to preventing further complications caused by the hypercoagulative state in COVID-19 patients. The optimal dose and time-dependent administration of anticoagulants remains unknown. The purpose of this study was to determine the mortality and bleeding risks of anticoagulants administered to COVID-19 patients. We collected data from articles that compared prophylactic and therapeutic anticoagulants in COVID-19 patients recorded online from studies that were published around 2020 to 2021. We were taking the articles from a scientific database such as ScienceDirect, Cochrane, ProQuest, PubMed, and Google Scholar based on the inclusion criteria. Data analysis was conducted using Review Manager Version 5.4.1 (Cochrane, Copenhagen, Denmark) using Mantel-Haenzel statistical method for categorical data to measure Relative Risk (RR) and 95% Confidence Interval (CI). We use a random-effect analysis model if P for heterogeneity (pHet <0.1) and a fixed-effect analysis model if pHet ≥0.1. Based on time dependent-manner, therapeutic anticoagulant showed no benefit in reducing mortality (RR = 0.69; 95% CI = 0.47 to 1.02). Beside, based on dose-dependent manner, prophylactic anticoagulant was found beneficial to prevent mortality (RR = 0.49; CI 95%; p = 0.02) compared to therapeutic. Therapeutic anticoagulants also showed higher risk of bleeding (RR = 0.27; CI 95%; p < 0.000001) compared to prophylactic. Therapeutic have no significantly benefit over prophylactic dose in reducing mortality rates. Therapeutic anticoagulant has a higher risk of bleeding in patients with COVID-19. Administer prophylactic dose is recommended due to the fewer side effects compared to the therapeutic dose.
抗凝治疗对于预防COVID-19患者高凝状态引起的进一步并发症至关重要。抗凝剂的最佳剂量和时间依赖性仍然是未知的。本研究的目的是确定COVID-19患者使用抗凝剂的死亡率和出血风险。我们收集了一些文章的数据,这些文章比较了2020年至2021年左右发表的研究中在线记录的COVID-19患者的预防性和治疗性抗凝剂。我们根据纳入标准从科学数据库(如ScienceDirect、Cochrane、ProQuest、PubMed和Google Scholar)中选取文章。数据分析采用Review Manager Version 5.4.1 (Cochrane, Copenhagen, Denmark),分类数据采用Mantel-Haenzel统计方法测量相对风险(Relative Risk, RR)和95%置信区间(95% Confidence Interval, CI)。如果P为异质性(pHet <0.1),我们使用随机效应分析模型;如果pHet≥0.1,我们使用固定效应分析模型。基于时间依赖性,抗凝治疗对降低死亡率没有益处(RR = 0.69;95% CI = 0.47 ~ 1.02)。此外,基于剂量依赖性,预防性抗凝剂有利于预防死亡(RR = 0.49;CI 95%;P = 0.02)。治疗性抗凝剂也显示出较高的出血风险(RR = 0.27;CI 95%;P < 0.000001)。治疗性剂量在降低死亡率方面没有明显优于预防性剂量。治疗性抗凝剂在COVID-19患者中出血的风险更高。由于副作用比治疗剂量少,建议使用预防剂量。
{"title":"Comparison of the Mortality and Bleeding Risk of Anticoagulant Doses in COVID-19 Patients: A Systematic Review and Meta-analysis","authors":"A. F. Purnomo, M. Syaban, I. Faratisha, Firstya Diyah Ekasiwi, M. Juwono, Nur Hudayana, Edwin Kinesya, Yusuf Mannagalli, E. Pasaribu","doi":"10.22146/ijp.2697","DOIUrl":"https://doi.org/10.22146/ijp.2697","url":null,"abstract":"Anticoagulant therapy becomes critical to preventing further complications caused by the hypercoagulative state in COVID-19 patients. The optimal dose and time-dependent administration of anticoagulants remains unknown. The purpose of this study was to determine the mortality and bleeding risks of anticoagulants administered to COVID-19 patients. We collected data from articles that compared prophylactic and therapeutic anticoagulants in COVID-19 patients recorded online from studies that were published around 2020 to 2021. We were taking the articles from a scientific database such as ScienceDirect, Cochrane, ProQuest, PubMed, and Google Scholar based on the inclusion criteria. Data analysis was conducted using Review Manager Version 5.4.1 (Cochrane, Copenhagen, Denmark) using Mantel-Haenzel statistical method for categorical data to measure Relative Risk (RR) and 95% Confidence Interval (CI). We use a random-effect analysis model if P for heterogeneity (pHet <0.1) and a fixed-effect analysis model if pHet ≥0.1. Based on time dependent-manner, therapeutic anticoagulant showed no benefit in reducing mortality (RR = 0.69; 95% CI = 0.47 to 1.02). Beside, based on dose-dependent manner, prophylactic anticoagulant was found beneficial to prevent mortality (RR = 0.49; CI 95%; p = 0.02) compared to therapeutic. Therapeutic anticoagulants also showed higher risk of bleeding (RR = 0.27; CI 95%; p < 0.000001) compared to prophylactic. Therapeutic have no significantly benefit over prophylactic dose in reducing mortality rates. Therapeutic anticoagulant has a higher risk of bleeding in patients with COVID-19. Administer prophylactic dose is recommended due to the fewer side effects compared to the therapeutic dose.","PeriodicalId":13520,"journal":{"name":"INDONESIAN JOURNAL OF PHARMACY","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78132214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
INDONESIAN JOURNAL OF PHARMACY
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1